| J9312 | Injection, rituximab, 10 mg | 8,950 | $60 | $563.9K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 32,550 | $10 | $325.5K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 73,600 | $1 | $294.4K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 7,750 | $30 | $263.5K |
| J0897 | Injection, denosumab, 1 mg | 10,260 | $20 | $184.7K |
| J3262 | Injection, tocilizumab, 1 mg | 24,560 | $10 | $122.8K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 1,100 | $60 | $64.6K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 490 | $90 | $43.5K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 560 | $50 | $27.3K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 790 | $10 | $7.8K |